Literature DB >> 27692989

Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease.

Young Youl Hyun1, Kyu-Beck Lee2, Kook-Hwan Oh3, Curie Ahn1, Sue Kyung Park4, Dong Wan Chae5, Tae-Hyun Yoo6, Kyu Hun Cho6, Yong-Soo Kim7, Young-Hwan Hwang8.   

Abstract

OBJECTIVE: Adiponectin (ADPN) has antiatherogenic, anti-inflammatory, and insulin-sensitizing effects. Serum ADPN levels are increased in patients with chronic kidney diseases (CKD), and higher ADPN is paradoxically a predictor of mortality in these patients. The aim of this study was to determine the association between serum ADPN levels and protein-energy wasting (PEW) in predialysis CKD.
METHOD: We examined serum ADPN concentrations and PEW in 1303 patients from the KNOW-CKD (KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease) study. PEW was defined as the presence of three or more of the following four indicators: serum albumin <3.8 g/dL, body mass index <23 kg/m2, urine creatinine excretion (UCE) below the lower quartile, and daily dietary protein intake <0.6 g/kg. We analyzed the association between PEW and ADPN using a multivariate regression model after adjustment for socioeconomic factors, comorbidities, and laboratory findings.
RESULTS: Among 1303 predialysis CKD patients, 72 (5.5%) had PEW. In multivariate logistic regression analysis, higher ADPN level was associated with PEW (odds ratio, 1.04; 95% confidence interval [CI], 1.01-1.08 by 1 μg/mL ADPN). The highest ADPN quartile was associated with PEW in comparison with the lowest quartile (odds ratio, 10.54; 95% CI, 1.28-86.74). In multiple linear regression with PEW indicators, ADPN was more strongly associated with UCE (β = -2.21; 95% CI, -4.13 to -0.28; R2 = 0.67).
CONCLUSION: High ADPN is independently associated with PEW. Among PEW indicators, serum ADPN is closely associated with UCE as an indirect measure of muscle mass. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adiponectin; Chronic kidney disease; Protein–energy wasting; Urine creatinine excretion

Mesh:

Substances:

Year:  2016        PMID: 27692989     DOI: 10.1016/j.nut.2016.06.014

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  9 in total

1.  Calcitriol and FGF-23, but neither PTH nor sclerostin, are associated with calciuria in CKD.

Authors:  J Ramalho; E M Petrillo; A P M Takeichi; R M A Moyses; S M Titan
Journal:  Int Urol Nephrol       Date:  2019-07-31       Impact factor: 2.370

Review 2.  Immunologic and endocrine functions of adipose tissue: implications for kidney disease.

Authors:  Qingzhang Zhu; Philipp E Scherer
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

3.  Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study.

Authors:  Chang-Yun Yoon; Yung Ly Kim; Seung Hyeok Han; Tae-Hyun Yoo; Su-Ah Sung; Woo-Kyung Chung; Dong-Wan Chae; Yong-Soo Kim; Curie Ahn; Kyu Hun Choi
Journal:  Diabetol Metab Syndr       Date:  2016-11-14       Impact factor: 3.320

Review 4.  The KNOW-CKD Study: What we have learned about chronic kidney diseases.

Authors:  Kook-Hwan Oh; Minjung Kang; Eunjeong Kang; Hyunjin Ryu; Seung Hyeok Han; Tae-Hyun Yoo; Soo Wan Kim; Dong-Wan Chae; Kyu-Beck Lee; Sue K Park; Yeong Hoon Kim; Curie Ahn
Journal:  Kidney Res Clin Pract       Date:  2020-06-30

5.  Impact of Preoperative Abdominal Visceral Adipose Tissue Area and Nutritional Status on Renal Function After Donor Nephrectomy in Japanese Living Donors for Renal Transplantation.

Authors:  Shunta Hori; Makito Miyake; Yosuke Morizawa; Yasushi Nakai; Kenta Onishi; Kota Iida; Daisuke Gotoh; Satoshi Anai; Kazumasa Torimoto; Katsuya Aoki; Tatsuo Yoneda; Nobumichi Tanaka; Katsunori Yoshida; Kiyohide Fujimoto
Journal:  Ann Transplant       Date:  2018-05-29       Impact factor: 1.530

6.  Association of High Serum Adiponectin with the Risk of Malnutrition and Worse Outcome in Head Trauma Patients; a Cohort study.

Authors:  Mohammed Ibrahim Mohialdeen Gubari; Mohammad Javad Hosseinzadeh-Attar; Mostafa Hosseini; Fadhil Ahmed Mohialdeen; Abdolreza Norouzy
Journal:  Arch Acad Emerg Med       Date:  2019-08-24

Review 7.  Adiponectin in Chronic Kidney Disease.

Authors:  Jarosław Przybyciński; Violetta Dziedziejko; Kamila Puchałowicz; Leszek Domański; Andrzej Pawlik
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

Review 8.  Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease.

Authors:  Sylwia Czaja-Stolc; Marta Potrykus; Marta Stankiewicz; Łukasz Kaska; Sylwia Małgorzewicz
Journal:  Nutrients       Date:  2022-03-31       Impact factor: 5.717

9.  Low serum adiponectin level is associated with better physical health-related quality of life in chronic kidney disease.

Authors:  Ji Hye Kim; Ji Min Han; Hyang Kim; Kyu-Beck Lee; Wookyung Chung; Yong-Soo Kim; Sue K Park; Dong Wan Chae; Curie Ahn; Kook-Hwan Oh; Young Youl Hyun
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.